January 2005
Taber's Cyclopedic Medical Dictionary;2005, p1723
Reference Entry
A definition for the term "polyangiitis" is presented. It referred to the inflammation of several blood vessels.


Related Articles

  • microangiitis.  // Taber's Cyclopedic Medical Dictionary;2005, p1356 

    A definition for the term "microangiitis" is presented. The term refers to an inflammation of very small blood vessels. The reference entry is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co. The pronunciation of the term is also provided.

  • Management of anesthesia in henoch schonlein purpura: a case report. Koca, Erdinc // Journal of Turgut Ozal Medical Center;2016, Vol. 23 Issue 4, p457 

    Henoch schonlein purpura (HSP) is the most common kind of acute small-vessel vasculitis especially affecting children. It is initiated by deposition of immune complexes as responses to infections such as group A streptococci, mycoplasma, Epstein -Barr, and Varicella zoster. HSP is characterized...

  • Polyarteritis Nodosa. Williams, David S. // Journal of Insurance Medicine;2006, Vol. 38 Issue 2, p144 

    Polyarteritis nodosa is a systemic necrotizing vasculitis of small and medium-sized arteries affecting multiple organ systems. Typical findings are illustrated.

  • vasculitis. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p783 

    An encyclopedia entry for "vasculitis" is presented. It is a medical term characterized by inflammatory destruction of blood vessels. Vasculitis affects the lining of the vessels that leads to restriction or stoppage of blood flow. It is attributed to minute bodies called immune complexes....

  • Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Millet, Arnaud; Pederzoli-Ribeil, Magali; Guillevin, Loïc; Witko-Sarsat, Véronique; Mouthon, Luc // Postgraduate Medical Journal;May2014, Vol. 90 Issue 1063, p290 

    Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides are a heterogeneous group of diseases corresponding to necrotising inflammation of small vessels with a wide range of clinical presentations. At least two of the diseases are believed to exhibit a common ground of...

  • Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis. Holding, Stephen; Fisher, Victoria J; Abuzakouk, Mohamed // Annals of Clinical Biochemistry;Mar2015, Vol. 52 Issue 2, p297 

    The article presents a study which aims to quantify the incidence of antibody switching. It states that the study reviewed all anti-neutrophil cytoplasmic antibody (ANCA) results in Hull and East Yorkshire Hospitals National Health Service Trust from January 2000 to August 2012. It is inferred...

  • Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis. Ateş, Aşkın; Karaaslan, Yaşar; Aksaray, Sebahat // Clinical Rheumatology;Apr2007, Vol. 26 Issue 4, p499 

    The objective of this study was to determine the diagnostic value for rheumatoid arthritis (RA) of antibodies to cyclic citrullinated peptides (anti-CCP) in patients with early arthritis and vasculitis. Sixty-four adult patients with early arthritis and disease duration of less than 4 months...

  • Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis. de Groot, Kirsten; Harper, Lorraine; Jayne, David R. W.; Suarez, Luis Felipe Flores; Gregorini, Gina; Gross, Wolfgang L.; Luqmani, Rashid; Pusey, Charles D.; Rasmussen, Niels; Sinico, Renato A.; Tesar, Vladimir; Vanhille, Philippe; Westman, Kerstin; Savage, Caroline O. S. // Annals of Internal Medicine;5/19/2009, Vol. 150 Issue 10, p670 

    Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)—associated vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily oral cyclophosphamide for induction of remission. Design: Randomized, controlled trial. Random assignments...

  • Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis. Chironi, G.; Pagnoux, C.; Simon, A.; Pasquinelli-Balice, M.; Del-Pino, M.; Gariepy, J.; Guillevin, L. // Heart;Jan2007, Vol. 93 Issue 1, p96 

    Background and objective: Although changes in smaller vessels is the hallmark of medium-sized and small-vessel vasculitis, it has been suggested that large arteries of such patients may also be affected by the early atherosclerotic process because of coexisting risk factors or systemic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics